<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

By Author

Lauren Wise


Alumni

Recent PhD graduate puts it all together with research

Six graduates were recently conferred their degrees from the CU Skaggs School of Pharmacy and Pharmaceutical Sciences through the CU Anschutz Graduate Program during the fall 2020 Commencement, Saturday, Dec 12. Philanthropic Advisor Lauren Wise had a chance to speak with one of the graduates, Reena Berman, about her experience pursuing her PhD in Toxicology. Here’s how Reena responded to the questions:


Author Lauren Wise | Publish Date December 19, 2020
Full Story

Alumni

"CU has given me everything that I have in the US.”

Lauren Wise with the Advancement Office recently had a conversation with 2019 CU Pharmacy alumnus Stefanos Aivazidis, who spoke on his time at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, pursuing his PhD in Toxicology. Below is the discussion between the two:


Author Lauren Wise | Publish Date November 21, 2020
Full Story

School of Pharmacy In the News

The Denver Post

Adderall, antibiotic shortages likely to continue into 2023, Colorado pharmacist says

news outletThe Denver Post
Publish DateDecember 07, 2022

Kelsey Schwander, PharmD, provides insight and advice to patients during this unprecedented pharmaceutical shortage. 

Full Story
Diversity in Action

Emerging Science

news outletDiversity in Action
Publish DateDecember 05, 2022

Dr. David Kroll, PhD, explains to Diversity In Action a history of cannabis research and clinical practice in the American medical system.

Full Story
Medscape

Can Cannabis Help Patients With MS?

news outletMedscape
Publish DateDecember 01, 2022

Jacci Bainbridge, PharmD, joined Medscape for its podcast on Multiple Sclerosis. In this episode, she speaks with Anne Cross, MD about cannabis use in patients with MS.

Full Story
Medscape

Time to Test Effects of CBD in Cardiovascular Disease?

news outletMedscape
Publish DateOctober 05, 2022

Robert Page, PharmD, weighs in on the need for well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease, based on evidence from preclinical studies showing that it has anti-inflammatory effects.

Full Story